Apical β-estradiol treatment led to a significant increase in pro MMP9 levels at the apical surface (Figure S2), whereas treatment with control and KC tear fluids did not induce any notable changes in the apical secretion of pro-MMP9 or MMP2 (Figure 2G). This evidence concerns the gene MMP9 and keratoconus.